YCCI News
EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities
- February 09, 2024
Researchers fill a gap in knowledge by finding that time is of the essence when treating hemorrhagic strokes, or brain bleeds, and not just ischemic strokes.
- February 08, 2024
First launched by Dr. Robert “Bob” S. Sherwin, the inaugural director of the Yale Center for Clinical Investigation, the Robert S. Sherwin YCCI All Scholar Day is a celebration of the center’s educational programs and the accomplishments of the trainees and scholars at all levels.
- February 06, 2024
YSPH researchers are studying obesity in Samoa, including the first longitudinal study of child health in the Pacific.
- February 05, 2024Source: CNN
Harlan Krumholz, MD, Harold H. Hines, Jr. Professor of Medicine (Cardiology), discusses two new studies that show treatment of obesity may be instrumental in improving heart health.
- February 05, 2024
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
- January 12, 2024Source: WTNH Channel 8
Ania Jastreboff, MD, PhD, Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management, is interviewed by WTNH-TV on muscle loss while losing weight.
- January 11, 2024
Yale-led study sheds light on additional health threats beyond the well-documented consequences of the opioid crisis.
- December 20, 2023
A new COVID-19 variant known as JN.1 is rapidly spreading across the United States and Europe as we head into peak holiday season travel time. Dr. Michael Cappello, MD, chair of the Yale School of Public Health’s Department of Epidemiology (Microbial Diseases), discusses the new variant, its threat potential, and what people can do to protect themselves from infection.
- December 14, 2023Source: Hartford Courant
Kevan Herold, MD, C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology), and Jennifer Sherr, MD, PhD, professor in pediatrics (endocrinology), discuss a new drug for type 1 diabetes.